Drug developer Chimerix Inc said its experimental ‘Ebola drug’ has been provided for potential use in patients. ‘
The CDC’s Frieden emphasized on Monday the importance of rehydration in treating Ebola patients, especially given the lack of available doses of the ‘experimental drug ZMapp’, produced by San Diego-based Mapp Biopharmaceutical...... Frieden has also said that a second experimental drug, made by Canada’s Tekmira Pharmaceuticals Corp, can be difficult for patients to take.
FYI....The Ebola patient in isolation at a Texas hospital has begun treatment with an experimental drug that was approved by the federal government ‘today’ for experimental use, the hospital said.
The announcement that he is now being treated with an experimental anti-viral medication called ‘brincidofovir’ comes ‘the same day that the Food and Drug Administration approved its use’ in experimental cases.